These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38220048)

  • 1. Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma.
    Sansa A; Valero C; Pujol A; Sauter B; Gayà J; Quer M; León X
    Acta Otorrinolaringol Esp (Engl Ed); 2024; 75(2):94-101. PubMed ID: 38220048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
    Guven DC; Erul E; Yilmaz F; Yasar S; Yildirim HC; Ercan F; Kaygusuz Y; Cayiroz K; Ucdal MT; Yesil F; Yazici G; Cengiz M; Gullu I; Aksoy S
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2471-2478. PubMed ID: 36565325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis.
    Lien MY; Hwang TZ; Wang CC; Hsieh CY; Yang CC; Wang CC; Lien CF; Shih YC; Yeh SA; Hsieh MC
    Target Oncol; 2024 Jan; 19(1):71-79. PubMed ID: 38041732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.
    Valero C; Pardo L; Sansa A; Garcia Lorenzo J; López M; Quer M; León X
    Head Neck; 2020 Feb; 42(2):336-343. PubMed ID: 31750591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of albumin levels prior to treatment in patients with head and neck squamous cell carcinoma.
    León X; Pardo L; Sansa A; Puig R; Serrano C; López M; Quer M; Valero C
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(4):204-211. PubMed ID: 31640850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pretreatment nomograms based on pan-immune-inflammation value for predicting clinical outcome in patients with head and neck squamous cell carcinoma.
    Chen Q; Wang SY; Chen Y; Yang M; Li K; Peng ZY; Xu CW; Yao XB; Li HH; Zhao Q; Cao YD; Bai YX; Li X
    Front Oncol; 2024; 14():1399047. PubMed ID: 38915366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of specific survival and local control through a recursive partitioning analysis in patients with head and neck carcinoma.
    León X; Rodriguez C; Rovira C; García J; López M; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(3):131-139. PubMed ID: 31060733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy.
    León X; Llansana A; Pérez-Ugarte L; García J; Valero C; Quer M; Camacho M
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):359-364. PubMed ID: 37931687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of preoperative pan-immune-inflammation value (PIV) for prognostication in patients with esophageal squamous cell carcinoma.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Int Immunopharmacol; 2023 Oct; 123():110805. PubMed ID: 37591121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential characteristics of patients with squamous cell carcinoma of the head and neck with no history of tobacco or alcohol use.
    León X; Pujals G; Sauter B; Neumann E; Pujol A; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(1):31-38. PubMed ID: 36709798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of head and neck squamous cell carcinomas in Spain during the 2006-2011 period].
    León Vintró X; Sánchez-Santos MT; Mañós Pujol M; Herranz González-Botas JJ; Esteban Ortega F; Nogués Orpí J
    Acta Otorrinolaringol Esp; 2015; 66(2):98-105. PubMed ID: 25109539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of extranodal extension in head and neck squamous cell carcinoma cN0 patients with occult metastatic neck nodes.
    Lop J; Rigó A; Codina A; de Juan J; Quer M; León X
    Acta Otorrinolaringol Esp (Engl Ed); 2018; 69(3):156-164. PubMed ID: 29033121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 14. External validation of the H-index (host index) in patients with head and neck squamous cell carcinomas.
    Sansa A; Valero C; Holgado A; Vásquez R; Quer M; Patel SG; León X
    Head Neck; 2023 Jan; 45(1):178-186. PubMed ID: 36225167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck squamous cell carcinoma in cigar smokers. Distinctive epidemiological and prognostic characteristics.
    León X; Pujals G; Bulboa C; García J; López M; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(4):222-229. PubMed ID: 34294221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma.
    de Juan J; García J; López M; Orús C; Esteller E; Quer M; León X
    JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):483-8. PubMed ID: 23681031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
    Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
    Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Characteristics of Patients With Squamous Cell Carcinoma of the Head and Neck According to Gender.
    León X; García J; López M; Holgado A; Llansana A; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(6):359-369. PubMed ID: 34844674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.